Which has grown faster, MRNA or REGN?

Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus REGN at 4.64%.

Does MRNA or REGN pay a bigger dividend?

REGN pays a dividend (0.50% yield), while MRNA has no payments in the available dividend history.

Is MRNA or REGN more profitable?

REGN runs the higher net margin — MRNA at -141.43% versus REGN at 27.86%.

How have MRNA and REGN total returns compared?

Over the past 5 years, MRNA delivered -11.04% and REGN delivered 5.38% annualized total return. Past performance doesn't predict future results.

Moderna, Inc. (MRNA) vs Regeneron Pharmaceuticals, Inc. (REGN)

A side-by-side comparison of Moderna, Inc. and Regeneron Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 5, 2026. Differences are shown without an overall score or investment verdict.

MRNA

Moderna, Inc.

$79.02B

$199.16HealthcareDelayed quote: Oct 5, 2026, 11:50 AM EDT

REGN

Regeneron Pharmaceuticals, Inc.

$74.73B

$725.39HealthcareDelayed quote: Oct 5, 2026, 11:50 AM EDT

Total return — MRNA vs REGN

growth of $100 · dividends reinvested · last 8y

MRNA +921.6% (+33.7%/yr)REGN +99.0% (+9.0%/yr)MRNA compounded faster over this window

Log scale — wide-divergence pair

MRNA REGN

MRNA vs REGN: by the numbers

•MRNA is the larger company ($79.02B vs $74.73B market cap).
•REGN is profitable (27.86% net margin) while MRNA runs a net loss (-141.43%).
•MRNA grew revenue faster over the past five years (19.33% vs 4.64% CAGR).
•REGN pays a dividend (0.50% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	MRNA	REGN
P/E ratio	N/A	17.94
Forward P/E	N/A	13.07
PEG ratio	N/A	2.83
P/S ratio	35.47	4.81
P/B ratio	11.69	2.36
EV / EBITDA	N/A	16.51
FCF yield	N/A	4.71%

Profitability

Metric	MRNA	REGN
Gross margin	55.35%	84.86%
Operating margin	-158.13%	25.56%
Net margin	-141.43%	27.86%
ROE	-46.61%	13.65%
ROIC	-39.16%	9.19%

Dividends

Metric	MRNA	REGN
Dividend yield	N/A	0.50%
Payout ratio	N/A	9.15%

Growth (annualized)

Metric	MRNA	REGN
Revenue CAGR (5Y)	19.33%	4.64%
EPS CAGR (5Y)	N/A	5.70%
FCF CAGR (5Y)	N/A	15.77%
Total return CAGR (5Y)	-11.04%	5.38%

Frequently asked

Which has grown faster, MRNA or REGN?: Over the past five years, MRNA grew revenue faster — MRNA at a 19.33% CAGR versus REGN at 4.64%.
Does MRNA or REGN pay a bigger dividend?: REGN pays a dividend (0.50% yield), while MRNA has no payments in the available dividend history.
Is MRNA or REGN more profitable?: REGN runs the higher net margin — MRNA at -141.43% versus REGN at 27.86%.
How have MRNA and REGN total returns compared?: Over the past 5 years, MRNA delivered -11.04% and REGN delivered 5.38% annualized total return. Past performance doesn't predict future results.

Go deeper

Full MRNA analysis Full REGN analysis Interactive comparison tool

Dig into the metrics

Regeneron Pharmaceuticals P/E ratio Regeneron Pharmaceuticals dividend yield Moderna ROE Regeneron Pharmaceuticals ROE Moderna operating margin Regeneron Pharmaceuticals operating margin Moderna revenue growth Regeneron Pharmaceuticals revenue growth Moderna free cash flow Regeneron Pharmaceuticals free cash flow

Moderna & Regeneron Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 5, 2026.